Let's Talk MS Medical cannabis and low-dose naltrexone
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Let's Talk MS Medical cannabis and low-dose naltrexone
-
ナレーター：
-
著者：
このコンテンツについて
How helpful is cannabis-based medication for people with multiple sclerosis? Ian Cook speaks to Professor Mike Barns, Chief Medical Officer at Drug Science, a group which works to provide an evidence base free from political or commercial influence. Proff Barns explains the work they are doing to make accessing cannabis-based medicine easier to access for people with multiple sclerosis, and how it can benefit patients.
We also hear from an MS patient who has been prescribed Sativex, a licenced cannabis-based medication, and their experiences with it.
Low-dose naltrexone is an off-licence medication that some people with MS say improves their symptoms. Linda Elsegood is the founder of The LDN Trust and has made it her life's work to try to get people with MS access to this drug. She tells Ian how the treatment completely changed her life.